ABOT Pharmaceuticals: Major
Health Technology
Mkt Cap
86.6B
P/E (TTM)
10.43
EPS
81.37
ROE
28.59%
Div Yield
4.52%
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Return on Equity (ROE) | 28.79% | 24.95% | 1.48% | 17.44% | 36.22% | |
| Return on Assets (ROA) | 18.79% | 13.95% | 0.73% | 9.52% | 22.20% | |
| Return on Invested Capital | 28.60% | 24.90% | 1.47% | 17.30% | 35.41% | |
| Gross Margin | 35.08% | 27.71% | 20.44% | 28.17% | 36.06% | |
| Operating Margin | 18.57% | 12.25% | 3.51% | 12.36% | 19.09% | |
| EBITDA Margin | — | 14.86% | 6.36% | 15.29% | 22.04% | |
| Net Margin | 10.57% | 7.68% | 0.47% | 6.10% | 14.02% | |
| Pre-Tax Margin | 17.90% | 13.23% | 3.68% | 12.48% | 19.76% | |
| Liquidity | ||||||
| Current Ratio | 2.32 | 1.99 | 1.38 | 1.50 | 1.97 | |
| Quick Ratio | 1.34 | 0.95 | 0.56 | 0.81 | 1.16 | |
| Leverage | ||||||
| Debt / Equity | 0.02 | 0.00 | 0.01 | 0.01 | 0.01 | |
| Debt / Assets | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | |
| LT Debt / Equity | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | |
| LT Debt / Assets | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Debt | -12.85B | -6.13B | -4.88B | -8.54B | -8.39B | |
| Total Debt | 487.98M | 52.23M | 158.22M | 247.29M | 227.69M | |
| Efficiency | ||||||
| Asset Turnover | 1.78 | 1.82 | 1.56 | 1.56 | 1.58 | |
| Inventory Turnover | 3.87 | 3.81 | 3.72 | 4.02 | 4.07 | |
| Per Share | ||||||
| Book Value Per Share | — | 242.33 | 186.28 | 174.73 | 177.27 | |
| Tangible Book Per Share | — | 242.32 | 186.16 | 174.45 | 176.77 | |
| Cash Per Share | — | 63.15 | 51.45 | 89.80 | 88.04 | |
| Total Debt Per Share | — | 0.53 | 1.62 | 2.53 | 2.33 | |
| Working Capital Per Share | — | 118.50 | 65.00 | 74.10 | 92.84 | |
| Shares & Market | ||||||
| Total Shares Outstanding | — | 97,900,302 | 97,900,302 | 97,900,302 | 97,900,302 | |
| Market Cap | — | 121.19B | 45.05B | 45.36B | 70.24B | |
| Enterprise Value | — | 115.06B | 40.18B | 36.81B | 61.85B | |
| Employees | — | 1,406 | 1,430 | 1,463 | 1,469 | |
| Shareholders | 3,015 | 3,015 | 3,015 | 3,015 | 3,015 | |